November 8th, 2021 · Common Contracts · 1000 similarSemper Paratus Acquisition Corp – INVESTMENT MANAGEMENT TRUST AGREEMENTThis Investment Management Trust Agreement (this “Agreement”) is made effective as of November 3, 2021 by and between Semper Paratus Acquisition Corporation, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company (the “Trustee”).
This Investment Management Trust Agreement (this “Agreement”) is made effective as of November 3, 2021 by and between Semper Paratus Acquisition Corporation, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company (the “Trustee”).
August 8th, 2017 · Common Contracts · 1000 similarNeonode, Inc – SECURITIES PURCHASE AGREEMENTThis Securities Purchase Agreement (this “Agreement”) is dated as of August 2, 2017, between Neonode Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of August 2, 2017, between Neonode Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
March 7th, 2022 · Common Contracts · 1000 similarIntegrated Rail & Resources Acquisition Corp – INDEMNITY AGREEMENTTHIS INDEMNITY AGREEMENT (this “Agreement”) is made as of March 4, 2022, by and between Integrated Rail and Resources Acquisition Corp., a Delaware corporation (the “Company”), and Troy O. Welch (“Indemnitee”).
THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of March 4, 2022, by and between Integrated Rail and Resources Acquisition Corp., a Delaware corporation (the “Company”), and Troy O. Welch (“Indemnitee”).
September 17th, 2010 · Common Contracts · 1000 similarAchillion Pharmaceuticals Inc – REGISTRATION RIGHTS AGREEMENTThis Registration Rights Agreement (this “Agreement”) is dated as of August 18, 2010 by and among Achillion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the several purchasers identified in the attached Exhibit A (each a “Purchaser” and collectively, the “Purchasers”).
This Registration Rights Agreement (this “Agreement”) is dated as of August 18, 2010 by and among Achillion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the several purchasers identified in the attached Exhibit A (each a “Purchaser” and collectively, the “Purchasers”).
October 19th, 2021 · Common Contracts · 1000 similarSanaby Health Acquisition Corp. I – WARRANT AGREEMENT between SANABY HEALTH ACQUISITION CORP. I and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated October 14, 2021THIS WARRANT AGREEMENT (this “Agreement”), dated as of October 14, 2021, is by and between Sanaby Health Acquisition Corp. I, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”).
THIS WARRANT AGREEMENT (this “Agreement”), dated as of October 14, 2021, is by and between Sanaby Health Acquisition Corp. I, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”).
January 14th, 2022 · Common Contracts · 1000 similarWestern Acquisition Ventures Corp. – 10,000,000 Units Western Acquisition Ventures Corp. UNDERWRITING AGREEMENTWestern Acquisition Ventures Corp., a Delaware corporation (the “Company”), hereby confirms its agreement with A.G.P./Alliance Global Partners (the “Representative”) and with the other underwriters named on Schedule A hereto (if any), for which the Representative is acting as representative (the Representative and such other underwriters being collectively referred to herein as the “Underwriters” or, each underwriter individually, an “Underwriter”), and with The Benchmark Company, LLC acting as the qualified independent underwriter (the “QIU”), as follows:
Western Acquisition Ventures Corp., a Delaware corporation (the “Company”), hereby confirms its agreement with A.G.P./Alliance Global Partners (the “Representative”) and with the other underwriters named on Schedule A hereto (if any), for which the Representative is acting as representative (the Representative and such other underwriters being collectively referred to herein as the “Underwriters” or, each underwriter individually, an “Underwriter”), and with The Benchmark Company, LLC acting as the qualified independent underwriter (the “QIU”), as follows:
October 31st, 2018 · Common Contracts · 1000 similarEquitrans Midstream Corp – CREDIT AGREEMENT Dated as of October 31, 2018 Among
March 21st, 2022 · Common Contracts · 1000 similarITHAX Acquisition Corp. – WARRANT AGREEMENTTHIS WARRANT AGREEMENT (this “Agreement”), dated as of January 27, 2021, is by and between ITHAX Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”).
THIS WARRANT AGREEMENT (this “Agreement”), dated as of January 27, 2021, is by and between ITHAX Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”).
December 2nd, 2019 · Common Contracts · 990 similarEncompass Health Corp – FIFTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of November 25, 2019, among ENCOMPASS HEALTH CORPORATION, The Lenders Party Hereto, BARCLAYS BANK PLC, as Administrative Agent and Collateral Agent, CITIGROUP GLOBAL MARKETS INC., as Syndication...FIFTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of November 25, 2019 (this “Agreement”), among ENCOMPASS HEALTH CORPORATION; the LENDERS party hereto; and BARCLAYS BANK PLC, as Administrative Agent and Collateral Agent.
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of November 25, 2019 (this “Agreement”), among ENCOMPASS HEALTH CORPORATION; the LENDERS party hereto; and BARCLAYS BANK PLC, as Administrative Agent and Collateral Agent.
July 19th, 2021 · Common Contracts · 914 similarCaribou Biosciences, Inc. – CARIBOU BIOSCIENCES, INC. (a Delaware corporation) [●] Shares of Common Stock UNDERWRITING AGREEMENT
December 27th, 2021 · Common Contracts · 876 similarGardiner Healthcare Acquisitions Corp. – UNDERWRITING AGREEMENTChardan Capital Markets, LLC 17 State Street, Suite 2100 New York, New York 10004 As Representative of the Underwriters named on Schedule A hereto
Chardan Capital Markets, LLC 17 State Street, Suite 2100 New York, New York 10004 As Representative of the Underwriters named on Schedule A hereto
October 28th, 2021 · Common Contracts · 846 similarChardan Nextech Acquisition Corp. – REGISTRATION RIGHTS AGREEMENTTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the [●] day of [●], 2021, by and among Chardan NexTech Acquisition Corp., a Delaware corporation (the “Company”) and the undersigned parties listed under Investor on the signature page hereto (each, an “Investor” and collectively, the “Investors”).
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the [●] day of [●], 2021, by and among Chardan NexTech Acquisition Corp., a Delaware corporation (the “Company”) and the undersigned parties listed under Investor on the signature page hereto (each, an “Investor” and collectively, the “Investors”).
November 13th, 2018 · Common Contracts · 791 similarNew Age Beverages Corp – UNDERWRITING AGREEMENT between NEW AGE BEVERAGES CORPORATION and ROTH CAPITAL PARTNERS, LLC And as Representatives of the Several Underwriters NEW AGE BEVERAGES CORPORATION UNDERWRITING AGREEMENTThe undersigned, New Age Beverages Corporation, a corporation formed under the laws of the State of Washington (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of New Age Beverages Corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC and A.G.P./Alliance Global Partners (hereinafter referred to as “you” (including its correlatives) or the “Representatives”) and with the other underwriters named on Schedule 1 hereto for which the Representatives are acting as representatives (the Representatives and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
The undersigned, New Age Beverages Corporation, a corporation formed under the laws of the State of Washington (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of New Age Beverages Corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC and A.G.P./Alliance Global Partners (hereinafter referred to as “you” (including its correlatives) or the “Representatives”) and with the other underwriters named on Schedule 1 hereto for which the Representatives are acting as representatives (the Representatives and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
August 9th, 2006 · Common Contracts · 786 similarVolcano CORP – VOLCANO CORPORATION and AMERICAN STOCK TRANSFER & TRUST COMPANY, as Rights Agent RIGHTS AGREEMENT Dated as of June 20, 2006This RIGHTS AGREEMENT (the “Agreement”), dated as of June 20, 2006, is entered into by and between VOLCANO CORPORATION, a Delaware corporation (the “Company”), and AMERICAN STOCK TRANSFER & TRUST COMPANY, a New York corporation, as Rights Agent (the “Rights Agent”).
This RIGHTS AGREEMENT (the “Agreement”), dated as of June 20, 2006, is entered into by and between VOLCANO CORPORATION, a Delaware corporation (the “Company”), and AMERICAN STOCK TRANSFER & TRUST COMPANY, a New York corporation, as Rights Agent (the “Rights Agent”).
May 5th, 2021 · Common Contracts · 727 similarWells Fargo Commercial Mortgage Trust 2021-C59 – MORTGAGE LOAN PURCHASE AGREEMENTThis Mortgage Loan Purchase Agreement (this “Agreement”), is dated and effective as of April 22, 2021, between Barclays Capital Real Estate Inc., as seller (in such capacity, together with its successors and permitted assigns hereunder, the “Mortgage Loan Seller” or “Seller”), Barclays Capital Holdings Inc. (“BCHI”) and Wells Fargo Commercial Mortgage Securities, Inc., as purchaser (in such capacity, together with its successors and permitted assigns hereunder, the “Purchaser”).
This Mortgage Loan Purchase Agreement (this “Agreement”), is dated and effective as of April 22, 2021, between Barclays Capital Real Estate Inc., as seller (in such capacity, together with its successors and permitted assigns hereunder, the “Mortgage Loan Seller” or “Seller”), Barclays Capital Holdings Inc. (“BCHI”) and Wells Fargo Commercial Mortgage Securities, Inc., as purchaser (in such capacity, together with its successors and permitted assigns hereunder, the “Purchaser”).
September 18th, 2020 · Common Contracts · 627 similarStrongbridge Biopharma PLC – 11,111,111 Ordinary Shares Strongbridge Biopharma plc UNDERWRITING AGREEMENTIntroductory. Strongbridge Biopharma plc, an Irish public limited company (registered no. 562659) (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 11,111,111 ordinary shares of the Company, par value $0.01 per share (the “Shares”). The 11,111,111 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,666,666 Shares as provided in Section 2. The additional 1,666,666 Shares to be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Offered Shares.” Jefferies LLC (“Jefferies”) and Stifel, Nicolaus & Company, Incorporated (“Stifel”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection
Introductory. Strongbridge Biopharma plc, an Irish public limited company (registered no. 562659) (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 11,111,111 ordinary shares of the Company, par value $0.01 per share (the “Shares”). The 11,111,111 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,666,666 Shares as provided in Section 2. The additional 1,666,666 Shares to be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Offered Shares.” Jefferies LLC (“Jefferies”) and Stifel, Nicolaus & Company, Incorporated (“Stifel”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection
November 23rd, 2021 · Common Contracts · 617 similarShoulderUP Technology Acquisition Corp. – INVESTMENT MANAGEMENT TRUST AGREEMENT
July 6th, 2015 · Common Contracts · 599 similarBioCardia, Inc. – BIOCARDIA, INC. [●] Shares of Common Stock Underwriting AgreementBioCardia, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 3,846,154 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 576,923 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
BioCardia, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 3,846,154 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 576,923 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
August 14th, 2008 · Common Contracts · 532 similarPatient Safety Technologies, Inc – SECURITIES PURCHASE AGREEMENTThis Securities Purchase Agreement (this “Agreement”) is dated as of August 1, 2008 by and between Patient Safety Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of August 1, 2008 by and between Patient Safety Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
November 19th, 2003 · Common Contracts · 523 similarWestinghouse Air Brake Technologies Corp – INDENTURE Dated as of August 6, 2003
September 29th, 2017 · Common Contracts · 509 similarCitigroup Commercial Mortgage Trust 2017-P8 – CITIGROUP COMMERCIAL MORTGAGE SECURITIES INC., PURCHASER and BARCLAYS BANK PLC, SELLER MORTGAGE LOAN PURCHASE AGREEMENT Dated as of September 1, 2017 Citigroup Commercial Mortgage Trust 2017-P8 Commercial Mortgage Pass-Through Certificates, Series 2017-P8in the Mortgaged Property. Such right of first offer has been subordinated to the Mortgage Loan pursuant to the terms of the comfort letter.
in the Mortgaged Property. Such right of first offer has been subordinated to the Mortgage Loan pursuant to the terms of the comfort letter.
January 31st, 2018 · Common Contracts · 467 similarCascadian Therapeutics, Inc. – AGREEMENT AND PLAN OF MERGERThis Agreement and Plan of Merger (this “Agreement”), dated as of January 30, 2018, is among Seattle Genetics, Inc., a Delaware corporation (“Parent”), Valley Acquisition Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and Cascadian Therapeutics, Inc., a Delaware corporation (the “Company”). Capitalized terms not otherwise defined herein shall have the respective meanings set forth in Annex A and Exhibit A attached hereto, as applicable.
This Agreement and Plan of Merger (this “Agreement”), dated as of January 30, 2018, is among Seattle Genetics, Inc., a Delaware corporation (“Parent”), Valley Acquisition Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and Cascadian Therapeutics, Inc., a Delaware corporation (the “Company”). Capitalized terms not otherwise defined herein shall have the respective meanings set forth in Annex A and Exhibit A attached hereto, as applicable.
November 8th, 2021 · Common Contracts · 428 similarSemper Paratus Acquisition Corp – REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENTTHIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of November 3, 2021, is made and entered into by and among Semper Paratus Acquisition Corporation, a Cayman Islands exempted company (the “Company”), Semper Paratus Sponsor LLC, a Delaware limited liability company (the “Sponsor”), Cantor Fitzgerald & Co., the representatives of the underwriters (“Cantor”), and the undersigned parties listed under Holder on the signature page hereto (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”).
THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of November 3, 2021, is made and entered into by and among Semper Paratus Acquisition Corporation, a Cayman Islands exempted company (the “Company”), Semper Paratus Sponsor LLC, a Delaware limited liability company (the “Sponsor”), Cantor Fitzgerald & Co., the representatives of the underwriters (“Cantor”), and the undersigned parties listed under Holder on the signature page hereto (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”).
September 21st, 2009 · Common Contracts · 419 similarTalecris Biotherapeutics Holdings Corp. – ] Shares TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. COMMON STOCK (PAR VALUE $0.01 PER SHARE) UNDERWRITING AGREEMENT
October 25th, 2021 · Common Contracts · 385 similarNewcourt Acquisition Corp – FORM OF INDEMNITY AGREEMENTNOW, THEREFORE, in consideration of the premises and the covenants contained herein and subject to the provisions of the letter agreement dated as of October 19, 2021 among the Company, Indemnitee and the other parties thereto pursuant to the Underwriting Agreement between the Company and the
NOW, THEREFORE, in consideration of the premises and the covenants contained herein and subject to the provisions of the letter agreement dated as of October 19, 2021 among the Company, Indemnitee and the other parties thereto pursuant to the Underwriting Agreement between the Company and the
November 17th, 2004 · Common Contracts · 380 similarElectric Aquagenics Unlimited Inc – REGISTRATION RIGHTS AGREEMENTREGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of October ___, 2004 by and between ELECTRIC AQUAGENICS UNLIMITED, INC., a Delaware corporation, with its principal office located at 1464 West 40 South, Suite 200, Lindon, UT 84042 (the "Company"), and CORNELL CAPITAL PARTNERS, LP, a Delaware limited partnership (the "Investor").
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of October ___, 2004 by and between ELECTRIC AQUAGENICS UNLIMITED, INC., a Delaware corporation, with its principal office located at 1464 West 40 South, Suite 200, Lindon, UT 84042 (the "Company"), and CORNELL CAPITAL PARTNERS, LP, a Delaware limited partnership (the "Investor").
April 30th, 2021 · Common Contracts · 374 similarJaguar Health, Inc. – SECURITIES PURCHASE AGREEMENTThis Securities Purchase Agreement (this “Agreement”) is dated as of April 29, 2021, between Jaguar Health, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of April 29, 2021, between Jaguar Health, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
September 12th, 2018 · Common Contracts · 374 similarJaguar Health, Inc. – REGISTRATION RIGHTS AGREEMENTTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 11, 2018 (the “Execution Date”), is entered into by and between JAGUAR HEALTH, INC., a Delaware corporation (the “Company”), and CHARLES CONTE, an individual resident of the State of New York (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Securities Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 11, 2018 (the “Execution Date”), is entered into by and between JAGUAR HEALTH, INC., a Delaware corporation (the “Company”), and CHARLES CONTE, an individual resident of the State of New York (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Securities Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
January 7th, 2021 · Common Contracts · 370 similarProPhase Labs, Inc. – SECURITIES PURCHASE AGREEMENTThis Securities Purchase Agreement (this “Agreement”) is dated as of January 5, 2021, between ProPhase Labs, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of January 5, 2021, between ProPhase Labs, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
April 6th, 2011 · Common Contracts · 341 similarAdcare Health Systems Inc – SECURITIES PURCHASE AGREEMENTSECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 31, 2011, by and among AdCare Health Systems, Inc., an Ohio corporation, with headquarters located at 5057 Troy Road, Springfield, Ohio 45502 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 31, 2011, by and among AdCare Health Systems, Inc., an Ohio corporation, with headquarters located at 5057 Troy Road, Springfield, Ohio 45502 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
October 8th, 2021 · Common Contracts · 338 similarSonendo, Inc. – ContractTHIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTION 5.3 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTION 5.3 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
August 5th, 2015 · Common Contracts · 319 similarProPhase Labs, Inc. – REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement (the “Agreement”), dated as of July 30, 2015, by and between PROPHASE LABS, INC., a corporation organized under the laws of Delaware, USA (the “Company”), and Dutchess Opportunity Fund, II, LP, a Delaware Limited Partnership (the “Investor”).
Registration Rights Agreement (the “Agreement”), dated as of July 30, 2015, by and between PROPHASE LABS, INC., a corporation organized under the laws of Delaware, USA (the “Company”), and Dutchess Opportunity Fund, II, LP, a Delaware Limited Partnership (the “Investor”).
December 29th, 2021 · Common Contracts · 317 similarProPhase Labs, Inc. – PROPHASE LABS, INC. Common Stock ($0.0005 par value per share) Sales AgreementProPhase Labs, Inc., a corporation formed under the laws of the State of Delaware (the “Company”), confirms its agreement (this “Agreement”) with ThinkEquity LLC (“ThinkEquity” or “Agent”), as follows:
ProPhase Labs, Inc., a corporation formed under the laws of the State of Delaware (the “Company”), confirms its agreement (this “Agreement”) with ThinkEquity LLC (“ThinkEquity” or “Agent”), as follows:
October 21st, 2009 · Common Contracts · 314 similarTalecris Biotherapeutics Holdings Corp. – TALECRIS BIOTHERAPEUTICS HOLDINGS CORP., as Company and THE SUBSIDIARIES NAMED HEREIN as Subsidiary Guarantors 7.75% SENIOR NOTES DUE 2016This INDENTURE dated as of October 21, 2009, is by and among Talecris Biotherapeutics Holdings Corp., a Delaware corporation (the “Company”), the Subsidiary Guarantors listed on the signature pages hereto, and The Bank of New York Mellon Trust Company, N.A., national banking association, as trustee (the “Trustee”).
This INDENTURE dated as of October 21, 2009, is by and among Talecris Biotherapeutics Holdings Corp., a Delaware corporation (the “Company”), the Subsidiary Guarantors listed on the signature pages hereto, and The Bank of New York Mellon Trust Company, N.A., national banking association, as trustee (the “Trustee”).
July 17th, 2002 · Common Contracts · 313 similarBlock Communications Inc – BY AND AMONG